IHL incannex healthcare limited
Add to My Watchlist 0.00% ! 4.1¢

News: IHL Incannex Healthcare Receives IRB Approval For Reposa Phase 2/3 Clinical Trial Protocol

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    17/01/24
    22:15
    Post #: 71932156

    Jan 17 (Reuters) - Incannex Healthcare Inc IQI0y.F :

    • INCANNEX HEALTHCARE:RECEIVES IRB APPROVAL FOR REPOSA PHASE 2/3 CLINICAL TRIAL PROTOCOL TO ASSESS IHL-42X DRUG IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA

    (([email protected];))

    Likes Created with Sketch. 30  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AII Building assets, producing critical minerals and slashing dependency on China
right-arrow Created with Sketch.
NEWS Gold producers Alkane and Mandalay make merger official
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.